Skip to content

Neonatal Bacterial Meningitis Cohort

A Multicenter Prospective Cohort Study on Neonatal Bacterial Meningitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03499652
Enrollment
10000
Registered
2018-04-17
Start date
2017-12-01
Completion date
2023-12-31
Last updated
2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Meningitis, Neonatal Infection

Brief summary

Neonatal bacterial meningitis (BM) is a devastating infection that occurs more commonly in neonates than in any other age group, and is associated with significant morbidity and mortality, especially in developing countries. In this study, we aimed to develop a clinical risk score model, according to the available clinical syndromes and commonly laboratory tests, for screening BM among full-term neonates in a large-scale retrospective cohort, and prospectively validated the risk score in multicenter cohort.

Detailed description

In this study, we aimed to develop a clinical risk score model, according to the available clinical syndromes and commonly laboratory tests, for screening BM among full-term neonates in a large-scale retrospective cohort, and prospectively validated the risk score in multicenter cohort.

Interventions

DIAGNOSTIC_TESTneonatal bacterial meningitis risk score

In the validation cohort,according to the neonatal bacterial meningitis risk score, we will suggest neonates who reach certain score to take a lumbar puncture, but we will not interfere with clinicians' decision

Sponsors

Shanghai Children's Medical Center
CollaboratorOTHER
Children's Hospital of Fudan University
CollaboratorOTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* Subject has a positive cerebrospinal fluid culture of bacterial pathogen(s) * Subject has a positive blood culture of bacterial pathogen and counts of white blood cells in cerebrospinal fluid ≥ 20×106/L * Subject has counts of white blood cells in cerebrospinal fluid ≥ 20×106/L and counts of neutrophils ≥ 10×106/L as well as suspected clinical symptoms

Exclusion criteria

* History of brain trauma, brain tumor, cerebral palsy, epilepsy, and ventricular shunt device * History of accepting neurosurgery * Subject has missing data

Design outcomes

Primary

MeasureTime frameDescription
neonatal bacterial meningitis risk score1 dayOur researchers grade the patients with the neonatal bacterial meningitis risk score to identify patients with bacterial meningitis, patients with risk score ≤ 3 points considered to be the low-risk group, and patients with risk score \> 3.1 points considered the high-risk group, and the risk score model has no maximum or minimum value.

Countries

China

Contacts

Primary ContactYongjun Zhang, doctor
zhangyongjun@stju.edu.cn+8602125078310

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026